Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Submit BE Raw Data, Interaction Study on Dapagliflozin-Rosuvastatin FDC: Expert Panel Tells Pure and Cure

Susmita Roy19 Aug 2025 3:02 PM IST

New Delhi: In line with the proposal presented by Pure and Cure Healthcare for the Dapagliflozin plus Rosuvastatin film-coated tablet, the Subject...

Bayer Gadoquatrane new drug application accepted for review by USFDA

Bayer Gets CDSCO Committee Nod to Manufacture, Market Darolutamide 300 mg for mHSPC, PMS Study Mandated

Susmita Roy18 Aug 2025 2:00 PM IST

New Delhi: Bayer Pharmaceuticals has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control...

Dr Reddys Labs receives positive EMA Committee opinion for proposed biosimilar of Prolia, Xgeva

Dr Reddy's Secures CDSCO Panel Approval to Import, Market Olutasidenib for AML

Susmita Roy17 Aug 2025 4:00 PM IST

New Delhi: In a significant development, the pharmaceutical major, Dr. Reddy's Laboratories, has got the go-ahead from the Subject Expert Committee...

Indian medical devices share increased from 10% to 30% of domestic requirements in last 5 years: DoP Secretary

Imported Devices Face 7.5-10% Duty, Domestic Devices GST at 12%, Govt Clarifies

Susmita Roy17 Aug 2025 4:00 PM IST

New Delhi: While imported medical devices attract a basic customs duty of 7.5-10% along with a 5% health cess, domestically manufactured medical...

Sun Pharma Halol facility gets OAI status from USFDA

Sun Pharma Gets CDSCO Panel Nod for Active PMS of Fexuprazan Hydrochloride Tablets

Susmita Roy15 Aug 2025 2:31 PM IST

New Delhi: Sun Pharma Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control...

Chemists' Body Warns of 55% Rise in Drug Abuse, Calls for Ban on 10-Minute Prescription Drug Delivery

Susmita Roy15 Aug 2025 11:30 AM IST

New Delhi: Speaking up against a worrying circumstance, the All India Organisation of Chemists and Druggists (AIOCD), representing over 12.40 lakh...

Setback to Torrent: CDSCO Panel Rejects Phase III Waiver Plea for Prucalopride Over Safety Data Gaps

Susmita Roy14 Aug 2025 9:28 PM IST

New Delhi: Citing that Torrent Pharmaceuticals has not presented adequate safety data on the synergistic effect of added excipients (propylene glycol,...

Pharma Firm, Director Under ED Lens Over Alleged Rs 60 Crore PNB Fraud

Susmita Roy13 Aug 2025 7:40 PM IST

New Delhi: As a part of an alleged multi-crore bank fraud, the Directorate of Enforcement (ED), Chandigarh, has begun investigating Ankur Drugs and...

NPPA Expert Committee Recommends Pricing for Abbott's Clarithromycin Tablet, Cautions Firm Over Form Error

Susmita Roy13 Aug 2025 6:22 PM IST

New Delhi: The Multidisciplinary Committee (MDC) of the National Pharmaceutical Pricing Authority (NPPA) has recommended fixing the retail price of...

CDSCO Panel Approves Emcures Phase III Clinical Trial of Semaglutide, Mandates Govt Trial Sites

Emcure Pharma Gets CDSCO Panel Nod for Phase III Trial of Semaglutide in Chronic Weight Management

Susmita Roy13 Aug 2025 5:39 PM IST

New Delhi: Accepting the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...

Maharashtra FDA Launches Special Drive to Inspect Liquid Oral Formulations

AIOCD Opposes Karnataka's Third-Party Pharmacy Inspection Plan, Warns of Legal, Data Risks

Susmita Roy12 Aug 2025 1:55 PM IST

New Delhi: Raising a deep concern regarding the proposal for third-party inspections in pharmacies through agencies such as the Quality Council of...

Precise Biopharma Gets CDSCO Panel Nod To Conduct Phase III Trial of Semaglutide Injection

Susmita Roy12 Aug 2025 12:47 PM IST

New Delhi: Accepting the bioequivalence study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok